Exchange: PNK Industry: Drug Manufacturers
1.96% $1.040
America/New_York / 30 nov 2023 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 13.94 mill |
EPS: | 0 |
P/E: | 0 |
Earnings Date: | Nov 20, 2023 |
SharesOutstanding: | 13.40 mill |
Avg Daily Volume: | 1.279 mill |
RATING 2023-07-26 |
---|
B+ |
Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Buy | |
Return On Equity: | Strong Sell | |
Return On Asset: | Neutral | |
DE: | Strong Buy | |
P/E: | Neutral | |
Price To Book: | Neutral |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE 0 | sector: PE 0 |
PE RATIO: COMPANY / INDUSTRY |
---|
0x |
Company: PE 0 | industry: PE 0 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 0.945 - 1.135 ( +/- 9.13%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-10-24 | Terzis Georgios | Buy | 51 485 | Common Stock, $.001 par value |
2023-10-12 | Siokas Grigorios | Buy | 6 712 | Common Stock, par value $0.001 per share |
2023-09-18 | Bhutawala Suhel | Sell | 0 | Common Stock, $.001 par value |
2023-04-03 | Aslidis Anastasios | Buy | 20 000 | Common Stock, $.001 par value |
2023-04-03 | Ziegler Manfred | Buy | 5 000 | Common Stock, $.001 par value |
INSIDER POWER |
---|
86.20 |
Last 96 transactions |
Buy: 36 383 515 | Sell: 4 757 918 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $1.040 (1.96% ) |
Volume | 0.124 mill |
Avg. Vol. | 1.279 mill |
% of Avg. Vol | 9.73 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.